Seqirus Presents New Safety Data Demonstrating Safety of Cell-Based Seasonal Influenza Vaccine on Pregnancy Outcomes
Go back to Seqirus Presents New Safety Data Demonstrating Safety of Cell-Based Seasonal Influenza Vaccine on Pregnancy Outcomes| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 367.15 -0.26 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $367.41 | 52 Week High | $114.49 | |||
| Open | $368.61 | 52 Week Low | $75.17 | |||
| Day High | $371.05 | P/E | 101.70 | |||
| Day Low | $365.48 | EPS | $3.61 | |||
| Volume | 59,067 | |||||
| (AMEX: CSLLY) | Delayed: 86.87 -0.05 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.92 | 52 Week High | $45.60 | |||
| Open | $85.98 | 52 Week Low | $33.39 | |||
| Day High | $87.10 | P/E | N/A | |||
| Day Low | $85.98 | EPS | $0.00 | |||
| Volume | 37,443 | |||||
